My bookmarksSign up free

Commission Delegated Regulation (EU) 2021/237 Article 2

Commission Delegated Regulation (EU) 2021/237 Article 2

Amendments to Delegated Regulation (EU) 2016/592

Article 2

Delegated Regulation (EU) 2016/592 is amended as follows: (1) Article 3 is amended as follows: (a) in paragraph 2, first subparagraph, point (a) is replaced by the following: ‘(a) 30 June 2022 in case no equivalence decision has been adopted pursuant to Article 13(2) of Regulation (EU) No 648/2012 for the purposes of Article 4 of that Regulation covering the OTC derivative contracts set out in the Annex to this Regulation in respect of the relevant third country;’; (b) the following paragraph 3 is added: ‘3.   By way of derogation from paragraphs 1 and 2, in respect of contracts pertaining to a class of OTC derivatives set out in the Annex, the clearing obligation shall take effect from 18 February 2022 where the following conditions are fulfilled: (a) the clearing obligation has not been triggered by 18 February 2021; (b) the contracts are novated for the sole purpose of replacing the counterparty established in the United Kingdom with a counterparty established in a Member State.’; (2) Article 4 is deleted.

Read the full instrument →

Other provisions in Commission Delegated Regulation (EU) 2021/237

Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗ · Data as of 2026-07-04

CitationArticle 2 of Commission Delegated Regulation (EU) 2021/237 (LawPlayer, data as of 2026-07-04)

© European Union, https://eur-lex.europa.eu, 1998-2026. Reuse authorised under Commission Decision 2011/833/EU, provided the source is acknowledged.

What to look at next